Table 1 Combined effects of the prednisone treatment (placebo vs. prednisone) and the treatment duration (Day 2 vs. Day 7) on heart rate (HR) and HR variability, expressed in absolute (low frequency: LFRR and high frequency amplitude: HFRR) and normalized (LFnu, HFnu and LF/HF) components
From: Effect of oral glucocorticoid intake on autonomic cardiovascular control
Placebo | Prednisone | |||
|---|---|---|---|---|
Day 2 | Day 7 | Day 2 | Day 7 | |
HR (bpm) | 59.0 ± 8.41 | 62.7 ± 12.3 | 66.9 ± 9.2 | 64.8 ± 9.4 |
LFRR (ms) | 34.0 ± 8.6 | 30.8 ± 7.7 | 31.9 ± 17.2 | 30.8 ± 13.8 |
HFRR (ms) | 57.0 ± 33.7 | 49.4 ± 38.1 | 44.5 ± 32.4 | 49.5 ± 35.9 |
LFnu | 0.41 ± 0.12 | 0.45 ± 0.14 | 0.45 ± 0.10 | 0.42 ± 0.12 |
HFnu | 0.59 ± 0.12 | 0.55 ± 0.14 | 0.55 ± 0.10 | 0.58 ± 0.12 |
LF/HF ratio | 0.76 ± 0.41 | 0.90 ± 0.47 | 0.87 ± 0.29 | 0.80 ± 0.37 |